2395 — Shin Nippon Biomedical Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Shin Nippon Biomedical Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 8,183 | 7,760 | 6,974 | 6,013 | 6,248 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -3,805 | -2,574 | -3,120 | -2,675 | -2,456 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 397 | -2,784 | -3,616 | 1,028 | 1,104 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5,953 | 4,002 | 2,107 | 6,976 | 8,327 |
| Capital Expenditures | -1,614 | -4,956 | -8,605 | -10,933 | -5,336 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2,654 | -975 | 1,698 | -758 | -1,455 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4,269 | -5,931 | -6,908 | -11,691 | -6,791 |
| Financing Cash Flow Items | -2.95 | 33.9 | -2.95 | 79.1 | -0.003 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4,912 | 6,266 | 5,319 | 5,914 | 4,514 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2,731 | 4,649 | 1,077 | 1,569 | 6,527 |